Schroder Investment Management Group
MDCO

Schroder Investment Management Group’s Medicines Co MDCO Stock Holding History

Schroder Investment Management Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-239,200
Closed -$5.34M – 1528
2014
Q3 		$5.34M Sell
239,200
-4,400
-2% -$112K 0.01% 773
2014
Q2 		$7.08M Sell
243,600
-67,900
-22% -$1.81M 0.01% 697
2014
Q1 		$8.85M Buy
+311,500
New +$10.3M 0.01% 659

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Schroder Investment Management Group's MDCO Position: Q4 2014 in Review

Schroder Investment Management Group sold out of Medicines Co (MDCO) in Q4 2014, closing a stake of 239,200 shares — an estimated $5.34M sold.

Schroder Investment Management Group first reported a position in MDCO in Q1 2014 and held it in 3 quarters. The position peaked at $8.85M in Q1 2014. 166 funds tracked by Wall St. Rank hold MDCO as of Q4 2014.

  • Schroder Investment Management Group reported no remaining Medicines Co position as of Q4 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 239,200 Medicines Co shares in Q4 2014, an estimated $5.34M.
  • Schroder Investment Management Group first reported a position in Medicines Co in Q1 2014 and held it in 3 quarters.
  • Schroder Investment Management Group's Medicines Co position peaked at $8.85M in Q1 2014.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.